Eur Respir J 2004; 23:391-395
Copyright ©ERS Journals Ltd 2004
Inhaled steroids and mortality in COPD: bias from unaccounted immortal time
S. Suissa
Division of Clinical Epidemiology, Royal Victoria Hospital, McGill University Health Centre, and the Depts of Epidemiology and Biostatistics and of Medicine, McGill University, Montreal, Canada
CORRESPONDENCE: S. Suissa, Division of Clinical Epidemiology, Royal Victoria Hospital, 687 Pine Avenue West, Ross 4.29, Montreal, Canada, H3A 1A1. Fax: 1 5148431493. E-mail: samy.suissa@clinepi.mcgill.ca
Keywords: biases, cohort studies, drug effectiveness, epidemiology, immortal time, pharmacoepidemiology
Received: June 3, 2003
Accepted October 5, 2003
This research was funded by grants from the Canadian Institutes of Health Research (CIHR) and Fonds de la recherche en Santé du Québec (FRSQ). The acquisition of the database was funded by grants from AstraZeneca, Boehringer Ingelheim and GlaxoSmithKline. The author is the recipient of a Distinguished Investigator award from the CIHR. This study is based on de-identified data provided by the Saskatchewan Dept of Health. The interpretation and conclusions contained herein do not necessarily represent those of the government of Saskatchewan or the Saskatchewan Dept of Health.
A recent observational study, which suggested that inhaled corticosteroids (ICS) with or without long-acting bronchodilators are effective at reducing all-cause mortality in chronic obstructive pulmonary disease (COPD) patients, may be subject to immortal time bias.
This bias was assessed using a population-based cohort of 3,524 newly treated COPD patients from Saskatchewan, Canada, observed from 19901999. Regular users of bronchodilators or ICS were followed for 3 yrs, during which time 860 deaths occurred. Cox's proportional hazards model was used to compare the hierarchical intention-to-treat approach employed in the recent study, a technique subject to bias from two sources of immortal time, with the conventional intention-to-treat approach and the according-to-treatment approach.
The adjusted rate ratio of death using the hierarchical intention-to-treat approach was 0.66 (95% confidence interval (CI) 0.570.76) for ICS use relative to bronchodilator use, compared with 0.75 (95% CI 0.620.90) with the conventional intention-to-treat approach. Conversely, the rate ratio was 0.94 (95% CI 0.811.09) with the according-to-treatment approach, which accounts for both sources of immortal time.
In this study, regular inhaled corticosteroid use in chronic obstructive pulmonary disease was not found to reduce all-cause mortality. Suggestion of this benefit from a previous observational study is the result of bias from unaccounted immortal time in its cohort design and analysis.
This article has been cited by other articles:

|
 |

|
 |
 
S. Suissa and P. J. Barnes
Inhaled corticosteroids in COPD: the case against
Eur. Respir. J.,
July 1, 2009;
34(1):
13 - 16.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. A. Falk, O. A. Minai, and Z. Mosenifar
Inhaled and Systemic Corticosteroids in Chronic Obstructive Pulmonary Disease
Proceedings of the ATS,
May 1, 2008;
5(4):
506 - 512.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M Sridhar, R Taylor, S Dawson, N J Roberts, and M R Partridge
A nurse led intermediate care package in patients who have been hospitalised with an acute exacerbation of chronic obstructive pulmonary disease
Thorax,
March 1, 2008;
63(3):
194 - 200.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Suissa
Immortal Time Bias in Pharmacoepidemiology
Am. J. Epidemiol.,
February 15, 2008;
167(4):
492 - 499.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Suissa, R. McGhan, D. Niewoehner, and B. Make
Inhaled Corticosteroids in Chronic Obstructive Pulmonary Disease
Proceedings of the ATS,
October 1, 2007;
4(7):
535 - 542.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Mikaeloff, G. Caridade, S. Assi, M. Tardieu, S. Suissa, and on behalf of the KIDSEP study group of the French
Hepatitis B vaccine and risk of relapse after a first childhood episode of CNS inflammatory demyelination
Brain,
April 1, 2007;
130(4):
1105 - 1110.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Suissa
Statin Use and Risks for Death and Hospitalization in Chronic Heart Failure
JAMA,
March 14, 2007;
297(10):
1057 - 1057.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Setoguchi, R. J. Glynn, J. Avorn, H. Mogun, and S. Schneeweiss
Statins and the Risk of Lung, Breast, and Colorectal Cancer in the Elderly
Circulation,
January 2, 2007;
115(1):
27 - 33.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Macie, K. Wooldrage, J. Manfreda, and N. R. Anthonisen
Inhaled Corticosteroids and Mortality in COPD.
Chest,
September 1, 2006;
130(3):
640 - 646.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Suissa
Observational Studies of Inhaled Corticosteroids in Chronic Obstructive Pulmonary Disease: Misconstrued Immortal Time Bias
Am. J. Respir. Crit. Care Med.,
February 15, 2006;
173(4):
464 - 464.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. F. Donohue
Combination Therapy for Chronic Obstructive Pulmonary Disease: Clinical Aspects
Proceedings of the ATS,
November 1, 2005;
2(4):
272 - 281.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. M. Samet
Inhaled Corticosteroids and Chronic Obstructive Pulmonary Disease: New and Improved Evidence?
Am. J. Respir. Crit. Care Med.,
August 15, 2005;
172(4):
407 - 408.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. A. Kiri, N. B. Pride, J. B. Soriano, and J. Vestbo
Inhaled Corticosteroids in Chronic Obstructive Pulmonary Disease: Results from Two Observational Designs Free of Immortal Time Bias
Am. J. Respir. Crit. Care Med.,
August 15, 2005;
172(4):
460 - 464.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Barber
"Chronic obstructive pulmonary disease": the diagnostic last refuge of the intellectually challenged?
Eur. Respir. J.,
October 1, 2004;
24(4):
710 - 711.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Suissa
From the Author
Eur. Respir. J.,
July 1, 2004;
24(1):
191 - 192.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V.A. Kiri, J. Vestbo, N.B. Pride, and J.B. Soriano
Inhaled steroids and mortality in COPD: bias from unaccounted immortal time.
Eur. Respir. J.,
July 1, 2004;
24(1):
190 - 191.
[Full Text]
[PDF]
|
 |
|
Copyright © 2004 by the European Respiratory Society.
|